Jae Young Lee

Array ( [id] => 11018307 [patent_doc_number] => 20160215260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'METHOD FOR INDUCING DOPAMINERGIC NEURON PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 14/916696 [patent_app_country] => US [patent_app_date] => 2014-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15071 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11018307 [patent_doc_number] => 20160215260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'METHOD FOR INDUCING DOPAMINERGIC NEURON PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 14/916696 [patent_app_country] => US [patent_app_date] => 2014-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15071 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14916696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858542 [patent_doc_number] => 20150038559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'Pharmaceutical Composition and Method for the Treatment of Neurodegenerative Diseases, in Particular Amyotrophic Lateral Sclerosis' [patent_app_type] => utility [patent_app_number] => 14/460110 [patent_app_country] => US [patent_app_date] => 2014-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7105 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14460110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10987509 [patent_doc_number] => 20160184455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING SMOOTH MUSCLE DYSFUNCTION' [patent_app_type] => utility [patent_app_number] => 14/910176 [patent_app_country] => US [patent_app_date] => 2014-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15887 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9838963 [patent_doc_number] => 20150031044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'GRAVITATIONAL FLUCTUATION STRESS LOADING METHOD, AIRCRAFT, AIRCRAFT-FLYING METHOD, METHOD FOR PROMOTING SEROTONIN-PRODUCING GENE EXPRESSION, SEROTONIN-PRODUCING METHOD, METHOD FOR STIMULATING CENTRAL NERVOUS SYSTEM, AND EFFICACY-MEASURING METHOD' [patent_app_type] => utility [patent_app_number] => 14/450521 [patent_app_country] => US [patent_app_date] => 2014-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 6993 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14450521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10297666 [patent_doc_number] => 20150182664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'Tissue Products Derived from Animals Lacking any Expression of Functional Alpha 1, 3 Galactosyltransferase' [patent_app_type] => utility [patent_app_number] => 14/449969 [patent_app_country] => US [patent_app_date] => 2014-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 37468 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14449969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11277262 [patent_doc_number] => 09493739 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-15 [patent_title] => 'Composition for proliferating stem cells by activating notch signaling' [patent_app_type] => utility [patent_app_number] => 14/337743 [patent_app_country] => US [patent_app_date] => 2014-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9943 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14337743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10905240 [patent_doc_number] => 20140308253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'ISOLATED POPULATIONS OF FEMALE GERMLINE STEM CELLS AND CELL PREPARATIONS AND COMPOSITIONS THEREOF' [patent_app_type] => utility [patent_app_number] => 14/315220 [patent_app_country] => US [patent_app_date] => 2014-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 30761 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17351017 [patent_doc_number] => 11225642 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-18 [patent_title] => Method for producing renal progenitor cells [patent_app_type] => utility [patent_app_number] => 14/897319 [patent_app_country] => US [patent_app_date] => 2014-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 7 [patent_no_of_words] => 13387 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10340736 [patent_doc_number] => 20150225741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'VECTORS FOR DELIVERY OF LIGHT SENSITIVE PROTEINS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/298553 [patent_app_country] => US [patent_app_date] => 2014-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17950 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14298553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10221966 [patent_doc_number] => 20150106959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'Porcine Animals Lacking Any Expression of Functional Alpha 1,3 Galactosyltransferase' [patent_app_type] => utility [patent_app_number] => 14/281464 [patent_app_country] => US [patent_app_date] => 2014-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21285 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14281464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10483597 [patent_doc_number] => 20150368617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-24 [patent_title] => 'METHOD FOR FORMING ENDOTHELIAL CELLS' [patent_app_type] => utility [patent_app_number] => 14/272168 [patent_app_country] => US [patent_app_date] => 2014-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 16336 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14272168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12341916 [patent_doc_number] => 09949465 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-24 [patent_title] => Atopic dermatitis model animal and use thereof [patent_app_type] => utility [patent_app_number] => 14/888398 [patent_app_country] => US [patent_app_date] => 2014-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 29 [patent_no_of_words] => 13394 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 262 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14888398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10712742 [patent_doc_number] => 20160058890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'SELECTIVE GENE THERAPY EXPRESSION SYSTEM' [patent_app_type] => utility [patent_app_number] => 14/782396 [patent_app_country] => US [patent_app_date] => 2014-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11027 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14782396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10398261 [patent_doc_number] => 20150283269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'RECONSTITUTED HUMAN IMMUNE SYSTEM IN A PATIENT DERIVED XENOGRAFT MOUSE MODEL' [patent_app_type] => utility [patent_app_number] => 14/245999 [patent_app_country] => US [patent_app_date] => 2014-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6374 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14245999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11018306 [patent_doc_number] => 20160215259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-07-28 [patent_title] => 'Method of Preparing Induced Neural Stem Cells Reprogrammed from Non-Neuronal Cells Using HMGA2' [patent_app_type] => utility [patent_app_number] => 14/782340 [patent_app_country] => US [patent_app_date] => 2014-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 15982 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14782340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9785727 [patent_doc_number] => 20140302547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'METHODS OF ISOLATING BIPOTENT HEPATIC PROGENITOR CELLS' [patent_app_type] => utility [patent_app_number] => 14/244763 [patent_app_country] => US [patent_app_date] => 2014-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11767 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14244763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10960352 [patent_doc_number] => 20140363380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES' [patent_app_type] => utility [patent_app_number] => 14/212715 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16551 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14212715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10704748 [patent_doc_number] => 20160050895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'TRANSGENIC NON-HUMAN ORGANISMS WITH NON-FUNCTIONAL TSPO GENES' [patent_app_type] => utility [patent_app_number] => 14/775650 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 35118 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9596699 [patent_doc_number] => 20140193380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'Technologies, Methods, and Products of Small Molecule Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells' [patent_app_type] => utility [patent_app_number] => 14/204372 [patent_app_country] => US [patent_app_date] => 2014-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9307 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14204372 [rel_patent_id] =>[rel_patent_doc_number] =>)